drug pricing

July 1, 2019

Study shows some generics can cost Medicare recipients more than brand-name drugs

Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.

By Jake Lowary